Literature DB >> 23537933

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.

Anja H Simonsen1, Justyna M C Bahl, Pia B Danborg, Veronica Lindstrom, Severin O Larsen, Anders Grubb, Niels H H Heegaard, Gunhild Waldemar.   

Abstract

Cerebrospinal fluid (CSF) is a potential source for new biomarkers due to its proximity to the brain. This study aimed to clarify the stability of the CSF proteome when undergoing pre-analytical factors. We investigated the effects of repeated freeze/thaw cycles, protease inhibitors and delayed storage for 4h, 24h or 14 days at -20°C, 4°C and room temperature (RT) after centrifugation compared with our standard practice of two hours at RT before placing the samples in an -80°C environment. The results were obtained using immunoassays for amyloid-beta 1-42 (Aβ42), tau, phosphorylated tau (P-tau) and cystatin C and using surface-enhanced laser desorption/ionisation time-of-flight (SELDI-TOF) mass spectrometry for proteomic profiling. Tau and P-tau were susceptible to repeated freeze/thaw cycles while SELDI-TOF analysis produced eight significant peaks and additional artefact peaks from samples with added protease inhibitors. Delayed storage for different durations and in different temperatures produced six significant SELDI-TOF peaks. Aβ42 and tau were susceptible to increased temperatures and the duration before storage, whereas P-tau and cystatin C were not. Transthyretin and several of its isoforms were found using SELDI-TOF and were susceptible to freeze/thaw cycles and to increased temperature and length of time prior to storage. We recommend that CSF should be collected and centrifuged immediately after sampling and prior to storage at -80°C without the addition of protease inhibitors. Freeze/thawing should be avoided because of the instability of tau, P-tau and transthyretin. Standardised CSF sampling, handling and storage for biomarker research are essential for accurately comparing the results obtained by different studies and institutions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23537933     DOI: 10.1016/j.jneumeth.2013.03.011

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  19 in total

1.  Total protein is an effective loading control for cerebrospinal fluid western blots.

Authors:  Mahlon A Collins; Jiyan An; Danielle Peller; Robert Bowser
Journal:  J Neurosci Methods       Date:  2015-05-22       Impact factor: 2.390

2.  Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) proteomic profiling of cerebrospinal fluid in the diagnosis of enteroviral meningitis: a proof-of-principle study.

Authors:  Ignacio Torres; Estela Giménez; Víctor Vinuesa; Tania Pascual; Juan Miguel Moya; Juan Alberola; Ana Martínez-Sapiña; David Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-27       Impact factor: 3.267

Review 3.  Bias-generating factors in biofluid amyloid-β measurements for Alzheimer's disease diagnosis.

Authors:  Sohui Park; YoungSoo Kim
Journal:  Biomed Eng Lett       Date:  2021-08-18

Review 4.  Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Authors:  Piotr Lewczuk; Peter Riederer; Sid E O'Bryant; Marcel M Verbeek; Bruno Dubois; Pieter Jelle Visser; Kurt A Jellinger; Sebastiaan Engelborghs; Alfredo Ramirez; Lucilla Parnetti; Clifford R Jack; Charlotte E Teunissen; Harald Hampel; Alberto Lleó; Frank Jessen; Lidia Glodzik; Mony J de Leon; Anne M Fagan; José Luis Molinuevo; Willemijn J Jansen; Bengt Winblad; Leslie M Shaw; Ulf Andreasson; Markus Otto; Brit Mollenhauer; Jens Wiltfang; Martin R Turner; Inga Zerr; Ron Handels; Alexander G Thompson; Gunilla Johansson; Natalia Ermann; John Q Trojanowski; Ilker Karaca; Holger Wagner; Patrick Oeckl; Linda van Waalwijk van Doorn; Maria Bjerke; Dimitrios Kapogiannis; H Bea Kuiperij; Lucia Farotti; Yi Li; Brian A Gordon; Stéphane Epelbaum; Stephanie J B Vos; Catharina J M Klijn; William E Van Nostrand; Carolina Minguillon; Matthias Schmitz; Carla Gallo; Andrea Lopez Mato; Florence Thibaut; Simone Lista; Daniel Alcolea; Henrik Zetterberg; Kaj Blennow; Johannes Kornhuber
Journal:  World J Biol Psychiatry       Date:  2017-10-27       Impact factor: 4.132

5.  Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression.

Authors:  Ludger Tebartz van Elst; Dominique Endres; Maike Michel; Bernd L Fiebich; Hanna Kuzior; Sophie Meixensberger; Benjamin Berger; Simon Maier; Kathrin Nickel; Kimon Runge; Dominik Denzel; Benjamin Pankratz; Miriam A Schiele; Katharina Domschke
Journal:  Transl Psychiatry       Date:  2021-05-21       Impact factor: 6.222

6.  Hypocretin-1 measurements in cerebrospinal fluid using radioimmunoassay: within and between assay reliability and limit of quantification.

Authors:  Adrienne Elisabeth van der Hoeven; Kevin van Waaij; Denise Bijlenga; Frederik Willem Cornelis Roelandse; Sebastiaan Overeem; Jaap Adriaan Bakker; Rolf Fronczek; Gert Jan Lammers
Journal:  Sleep       Date:  2022-07-11       Impact factor: 6.313

Review 7.  A consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.

Authors:  Sun Ah Park; Ju Hee Kang; Eun Suk Kang; Chang Seok Ki; Jee Hoon Roh; Young Chul Youn; Seong Yoon Kim; Sang Yun Kim
Journal:  J Clin Neurol       Date:  2015-04       Impact factor: 3.077

8.  Chasing the Effects of Pre-Analytical Confounders - A Multicenter Study on CSF-AD Biomarkers.

Authors:  Maria João Leitão; Inês Baldeiras; Sanna-Kaisa Herukka; Maria Pikkarainen; Ville Leinonen; Anja Hviid Simonsen; Armand Perret-Liaudet; Anthony Fourier; Isabelle Quadrio; Pedro Mota Veiga; Catarina Resende de Oliveira
Journal:  Front Neurol       Date:  2015-07-08       Impact factor: 4.003

9.  Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome.

Authors:  Elise Aasebø; Jill Anette Opsahl; Yngvild Bjørlykke; Kjell-Morten Myhr; Ann Cathrine Kroksveen; Frode S Berven
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Laboratory-based clinical audit as a tool for continual improvement: an example from CSF chemistry turnaround time audit in a South-African teaching hospital.

Authors:  Lucius C Imoh; Mubanga Mutale; Christopher T Parker; Rajiv T Erasmus; Annalise E Zemlin
Journal:  Biochem Med (Zagreb)       Date:  2016       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.